African trial of novel HIV vaccine candidate starts
Vaccine aims to combat numerous HIV strains, a key requirement of any vaccine to end the HIV/AIDs epidemic
Vaccine aims to combat numerous HIV strains, a key requirement of any vaccine to end the HIV/AIDs epidemic
Johan Engström, Senior Scientist at Gyros Protein Technologies, discusses the challenges of measuring high-affinity interactions of ligands in cancer immunotherapy
Continued emergence of SARS-CoV-2 variants highlights importance of sequencing for accurate COVID-19 tracking and surveillance
Will enable cancer researchers to accelerate identification and optimization of therapeutic leads by better decoding KRAS mutations present in 25% of tumors
The acquisition allows full-scale entry into the global life sciences business
From tackling COVID-19 variants to therapeutic discovery, novel organoids and more, advance your assay research with these exclusive interviews and free resources